Northwestern Medicine is now using Cytalux, an FDA‑approved imaging agent that causes cancer cells to fluoresce under near‑infrared light, helping surgeons visualize and remove cancerous tissue more precisely during lung surgery. The first procedure with Cytalux was performed by Justin Karush, DO, surgical director of the Canning Thoracic Institute at Northwestern Medicine Palos Hospital, on […]
To access this post, you must purchase South Suburban News Subscription.